诱导多能干细胞来源的人骨髓类器官的开发:用于自主造血及患者来源造血干祖细胞植入
研究开发了诱导多能干细胞(iPSC)来源的人骨髓类器官模型,可复现骨髓微环境,支持正常供者及骨髓增生异常综合征(MDS)患者来源的造血干祖细胞(HSPC)迁移、增殖并维持自我更新和原始遗传特征,MDS HSPC在类器官内的分化模式与正常多系造血显著不同,且与疾病临床表现相关。
要点
- iPSC来源人骨髓类器官形成内皮、基质和造血细胞的三维网络,模拟自主人骨髓微环境。
- 正常供者及MDS患者骨髓来源HSPC可迁移至类器官血管龛并增殖,维持自我更新和原始遗传特征。
- MDS HSPC在类器官内的分化模式与正常HSPC多系造血显著不同,并与疾病临床表现相关。
核心结论
- iPSC来源人骨髓类器官模型可用于研究人造血及血液病病理生理,为个性化医疗和治疗干预提供新途径。
研究设计与样本
- 研究开发了iPSC来源的人骨髓类器官模型,用于植入正常供者及MDS患者来源的HSPC。
主要发现
- 先进显微镜验证类器官内形成内皮、基质和造血细胞的复杂三维网络,类似自主人骨髓微环境。
- 正常供者或MDS患者骨髓来源HSPC可迁移至类器官血管龛并增殖,维持自我更新和原始遗传特征。
- 类器官内MDS HSPC的分化模式与正常HSPC多系造血显著不同,且与疾病临床表现相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Current efforts in translational studies in hematology often rely on immunodeficient mouse models for engrafting patient-derived hematopoietic stem and progenitor cells (HSPCs), yet these models often face challenges in effectively engrafting cells from patients with various diseases, such as myelodysplastic syndromes (MDSs). In this study, we developed an induced pluripotent stem cell (iPSC)-derived human bone marrow organoid model that closely replicates the bone marrow microenvironment, facilitating the engraftment of HSPCs derived from patients with MDS, thereby mirroring the patients' distinct disease characteristics. Specifically, using advanced microscopy, we verified the development of a complex 3-dimensional network of endothelial, stromal, and hematopoietic cells within organoids, resembling the autonomous human marrow microenvironment. Furthermore, we showed that HSPCs derived from the donor bone marrow of normal individuals or patients with MDS can migrate to and proliferate within the organoid vascular niche while maintaining self-renewal and original genetic profiles. Within the organoids, the differentiation patterns of MDS HSPCs were significantly distinct from those of multilineage hematopoiesis in normal HSPCs, which can be correlated with the clinical manifestations of the disease. These findings underscore the significance of the organoid model in studying human hematopoiesis and the pathophysiology of hematologic diseases, thereby offering new avenues for personalized medicine and therapeutic interventions.
引用
- Ren K, Li E, Aydemir I, et al. Development of iPSC-derived human bone marrow organoid for autonomous hematopoiesis and patient-derived HSPC engraftment. Blood Adv. 2025. PMID: 39471483. doi:10.1182/bloodadvances.2024013361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。